A study to evaluate the Safety, In-Use Tolerability and Efficacy of a test product in reducing acne and acne spots on the face.
- Registration Number
- CTRI/2023/10/058218
- Lead Sponsor
- Himalaya Wellness Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 102
1)Subjects having good general health as determined by the Investigator on the basis of medical history. Subjects with acne-prone skin and with mild to moderate acne condition as per IGA scale and acne prone skin.
2)Subjects with oily skin having Sebumeter measurement > 180 (µg/cm2).
3)Female subjects of childbearing potential must have a negative urine pregnancy test performed on screening and enrolment visit.
4)Subjects who are not under any dermatologic treatment for acne and scar/ prescribed medications.
1)Subjects with drug induced acne as disclosed by subjects.
2)Subjects undergoing treatment for skin lightening or subjects using other marketed skin lightening products during the study period or in the past 6 weeks.
3)Subjects who are receiving topical or systemic treatments for acne or acne marks.
4)Subjects receiving medications (e.g., steroids or anti-histamines) which would compromise the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of acne severity (in terms of reducing acne) using Investigator global assessment (IGA) and counting of inflammatory and non-inflammatory lesions.Timepoint: Day 01 (before application to Day 29 (plus 2 days)
- Secondary Outcome Measures
Name Time Method